Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine + sufentanil versus sufentanil or hydromorphone for post-cesarean patient-controlled analgesia
ChiCTR2600131987Phase 4Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing Oliceridine and sufentanil group, Sufentanil group and Hydromorphone group (3 arms). Primary endpoint: Postoperative 24-hour Numeric Rating Scale score. Started Mar 2025; status: completed.
02
Drugs
oliceridinesufentanilhydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600131987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131987.